An Age-related Decline in Interleukin-10 May Contribute to the Increased Expression of Interleukin-6 in Brain of Aged Mice
Overview
Neurology
Authors
Affiliations
Objectives: The DNA-binding activity of nuclear factor kappaB (NFkappaB) is elevated in brain of aged mice, resulting in elevated levels of the inflammatory cytokine interleukin (IL)-6. The purpose of this study was to determine if in the brain of aged mice a decrease in the anti-inflammatory cytokine IL-10 contributes to the increase in IL-6.
Methods: In initial studies coronal brain sections and glial cells from adult (6-months-old) and aged (24-months-old) mice were incubated in the presence or absence of lipopolysaccharide (LPS) and the concentrations of IL-6 and IL-10 in supernatants were determined. In subsequent studies, the effect of recombinant murine IL-10 on constitutive and inducible NFkappaB activity, IL-6 mRNA expression and IL-6 protein secretion by glia cultured from brains of adult and aged mice was determined.
Results: Coronal brain sections and glia from aged mice secreted more IL-6 and less IL-10 than brain sections and glia from adults. This effect of age was evident in the absence and presence of LPS and suggested that a decrease in IL-10 production permitted increased IL-6 production. Consistent with this idea, treatment of glia from aged mice with recombinant IL-10 decreased both constitutive and inducible binding of NFkappaB to the IL-6 gene promoter. The decrease in NFkappaB activity was associated with a reduction of IL-6 mRNA and protein. Exogenous IL-10, however, had no effect on NFkappaB activity, which was undetectable in unstimulated glia from adult mice, and did not decrease steady-state levels of IL-6 mRNA or IL-6 protein secretion.
Conclusions: Collectively, these studies suggest that IL-10 constrained IL-6 gene expression in the adult brain, but in the aged brain it decreased and thus enabled a cascade of intracellular events that increased expression of the IL-6 gene.
Soelter T, Howton T, Wilk E, Whitlock J, Clark A, Birnbaum A J Cell Commun Signal. 2025; 19(1):e70006.
PMID: 40026671 PMC: 11870853. DOI: 10.1002/ccs3.70006.
Soelter T, Howton T, Wilk E, Whitlock J, Clark A, Birnbaum A bioRxiv. 2024; .
PMID: 38826305 PMC: 11142088. DOI: 10.1101/2024.05.21.595199.
Gurung P, Lim J, Thapa Magar T, Shrestha R, Kim Y Antioxidants (Basel). 2024; 13(4).
PMID: 38671881 PMC: 11047375. DOI: 10.3390/antiox13040433.
Glaucoma: from pathogenic mechanisms to retinal glial cell response to damage.
Fernandez-Albarral J, Ramirez A, de Hoz R, Matamoros J, Salobrar-Garcia E, Elvira-Hurtado L Front Cell Neurosci. 2024; 18:1354569.
PMID: 38333055 PMC: 10850296. DOI: 10.3389/fncel.2024.1354569.
Zahedi A, Daneshpour M, Akbarzadeh M, Hedayati M, Azizi F, Zarkesh M Heliyon. 2023; 9(9):e19911.
PMID: 37809533 PMC: 10559325. DOI: 10.1016/j.heliyon.2023.e19911.